KOREA PHARMA Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 20 shareholders own 64.92% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
26%	Jaedon Park	2,840,000	₩50.4b	0%	no data
15.8%	Eun-Hee Park	1,720,000	₩30.5b	0%	no data
13.8%	Yoonseok Park	1,500,000	₩26.6b	0%	no data
7.15%	Keunhee Park	780,000	₩13.9b	0%	no data
0.47%	Byungjin Lee	51,535	₩915.3m	0%	no data
0.38%	Jinwoo Lee	41,399	₩735.2m	0%	no data
0.35%	Bongjun Kim	38,306	₩680.3m	0%	no data
0.31%	Seunghui Han	33,591	₩596.6m	0%	no data
0.28%	Seungwan Kim	30,325	₩538.6m	0%	no data
0.17%	Chanbok Lee	18,364	₩326.1m	0%	no data
0.15%	Dimensional Fund Advisors LP	16,353	₩290.4m	0%	no data
0.04%	Janghui Lee	4,355	₩77.3m	0%	no data
0.019%	Mi-Seong Park	2,100	₩37.3m	0%	no data
0.017%	Namhun Kim	1,815	₩32.2m	0%	no data
0.0095%	Muhwan An	1,038	₩18.4m	0%	no data
0.0072%	Jin-hyeong Kim	790	₩14.0m	0%	no data
0.0041%	Pan-gil Choi	450	₩8.0m	0%	no data
0.00024%	Invesco Capital Management LLC	26	₩464.9k	0%	no data
0.00014%	Sang-cheon Lee	15	₩271.2k	0%	no data
0.00013%	Hanwha Asset Management Co. Ltd.	14	₩251.8k	0%	no data